Detalles de la búsqueda
1.
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
N Engl J Med
; 388(6): 489-498, 2023 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780674
2.
The changing landscape of small cell lung cancer.
Cancer
; 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38470453
3.
JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer.
Cancer
; 128(1): 65-74, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478166
4.
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
Br J Cancer
; 126(3): 514-520, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480094
5.
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).
Oncologist
; 26(3): e435-e444, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32951293
6.
Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. Reply.
N Engl J Med
; 388(17): 1629-1630, 2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099350
7.
Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.
Cancer Immunol Immunother
; 70(10): 2819-2833, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651148
8.
Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
Int J Cancer
; 147(2): 392-403, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618441
9.
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
Cancer
; 125(3): 382-390, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30343497
10.
Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.
Int J Cancer
; 143(10): 2400-2408, 2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978465
11.
Functional variants in DCAF4 associated with lung cancer risk in European populations.
Carcinogenesis
; 38(5): 541-551, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28383684
12.
Current Treatments for Surgically Resectable, Limited-Stage, and Extensive-Stage Small Cell Lung Cancer.
Oncologist
; 22(12): 1510-1517, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28778960
13.
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.
Oncologist
; 22(2): 189-198, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28188257
14.
Targeted Therapies for Lung Cancer.
Cancer Treat Res
; 170: 165-82, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27535394
15.
The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung Cancer.
Curr Treat Options Oncol
; 17(4): 18, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26961971
16.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Lancet Oncol
; 16(3): 257-65, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25704439
17.
A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer.
Oncologist
; 20(2): 105-6, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25616430
18.
ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.
Oncology (Williston Park)
; 28(8): 706-10, 712, 714 passim, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25140629
19.
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.
J Clin Oncol
; 42(10): 1110-1113, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215351
20.
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance).
J Thorac Cardiovasc Surg
; 167(1): 338-347.e1, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37473998